Disarm Therapeutics

About:

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

Website: https://www.disarmtx.com/

Twitter/X: disarmtx

Top Investors: AbbVie, Atlas Venture, Lightstone Ventures, Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship

Description:

Disarm Therapeutics is a biotechnology company that creates disease-modifying therapeutics for patients with axonal degeneration. Its drugs prevent the loss of axons and treat neurological diseases including multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies that enable patients to avail treatment for acute diseases of the central, ocular, and peripheral nervous systems. Disarm Therapeutics was founded in 2016 and is headquartered in Cambridge, Massachusetts.